SAM
VRTX icon

Secure Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Secure Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
+411
New +$182K 0.03% 314
2025
Q2 		– Sell
-461
Closed -$224K – 363
2025
Q1 		$224K Buy
+461
New +$215K 0.04% 280

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Secure Asset Management's VRTX Position: Q2 2026 in Review

Secure Asset Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 411 shares worth $204K. The stake represents 0.03% of the portfolio and ranks #314 among its holdings. This is a return to the name: Secure Asset Management previously reported a position in VRTX as recently as Q1 2025.

Secure Asset Management first reported a position in VRTX in Q1 2025 and has held it in 2 quarters since. The position peaked at $224K in Q1 2025. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Secure Asset Management held 411 shares of Vertex Pharmaceuticals worth $204K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Secure Asset Management position in Q2 2026.
  • Vertex Pharmaceuticals made up 0.03% of Secure Asset Management's portfolio in Q2 2026, its #314 holding.
  • Secure Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • Secure Asset Management's Vertex Pharmaceuticals position peaked at $224K in Q1 2025.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Secure Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.